Global Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Research Report 2023

Publication ID:

PB501240004

Publication Date:

January 24, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

Highlights
The global Transcatheter Aortic Valve Implantation (TAVI) System market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Transcatheter Aortic Valve Implantation (TAVI) System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Transcatheter Aortic Valve Implantation (TAVI) System is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global manufacturers of Transcatheter Aortic Valve Implantation (TAVI) System include Colibri, NVT AG, Abbott, Strait Access Technologies, JenaValve Technology, Inc., Boston Scientific, Medtronic and MicroPort, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Transcatheter Aortic Valve Implantation (TAVI) System, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Transcatheter Aortic Valve Implantation (TAVI) System.
The Transcatheter Aortic Valve Implantation (TAVI) System market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Transcatheter Aortic Valve Implantation (TAVI) System market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Transcatheter Aortic Valve Implantation (TAVI) System manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.
By Company
Colibri
NVT AG
Abbott
Strait Access Technologies
JenaValve Technology, Inc.
Boston Scientific
Medtronic
MicroPort
Segment by Type
Less than 20mm
20-25mm
Great than 25mm
Segment by Application
Elderly Patients
Other Patients
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Transcatheter Aortic Valve Implantation (TAVI) System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Transcatheter Aortic Valve Implantation (TAVI) System in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Overview
1.1 Product Overview and Scope of Transcatheter Aortic Valve Implantation (TAVI) System
1.2 Transcatheter Aortic Valve Implantation (TAVI) System Segment by Type
1.2.1 Global Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Value Comparison by Type (2023-2029)
1.2.2 Less than 20mm
1.2.3 20-25mm
1.2.4 Great than 25mm
1.3 Transcatheter Aortic Valve Implantation (TAVI) System Segment by Application
1.3.1 Global Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Value by Application: (2023-2029)
1.3.2 Elderly Patients
1.3.3 Other Patients
1.4 Global Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Size Estimates and Forecasts
1.4.1 Global Transcatheter Aortic Valve Implantation (TAVI) System Revenue 2018-2029
1.4.2 Global Transcatheter Aortic Valve Implantation (TAVI) System Sales 2018-2029
1.4.3 Global Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Competition by Manufacturers
2.1 Global Transcatheter Aortic Valve Implantation (TAVI) System Sales 麻豆原创 Share by Manufacturers (2018-2023)
2.2 Global Transcatheter Aortic Valve Implantation (TAVI) System Revenue 麻豆原创 Share by Manufacturers (2018-2023)
2.3 Global Transcatheter Aortic Valve Implantation (TAVI) System Average Price by Manufacturers (2018-2023)
2.4 Global Transcatheter Aortic Valve Implantation (TAVI) System Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Transcatheter Aortic Valve Implantation (TAVI) System, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Transcatheter Aortic Valve Implantation (TAVI) System, Product Type & Application
2.7 Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Competitive Situation and Trends
2.7.1 Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Transcatheter Aortic Valve Implantation (TAVI) System Players 麻豆原创 Share by Revenue
2.7.3 Global Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Transcatheter Aortic Valve Implantation (TAVI) System Retrospective 麻豆原创 Scenario by Region
3.1 Global Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Transcatheter Aortic Valve Implantation (TAVI) System Global Transcatheter Aortic Valve Implantation (TAVI) System Sales by Region: 2018-2029
3.2.1 Global Transcatheter Aortic Valve Implantation (TAVI) System Sales by Region: 2018-2023
3.2.2 Global Transcatheter Aortic Valve Implantation (TAVI) System Sales by Region: 2024-2029
3.3 Global Transcatheter Aortic Valve Implantation (TAVI) System Global Transcatheter Aortic Valve Implantation (TAVI) System Revenue by Region: 2018-2029
3.3.1 Global Transcatheter Aortic Valve Implantation (TAVI) System Revenue by Region: 2018-2023
3.3.2 Global Transcatheter Aortic Valve Implantation (TAVI) System Revenue by Region: 2024-2029
3.4 North America Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Facts & Figures by Country
3.4.1 North America Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Transcatheter Aortic Valve Implantation (TAVI) System Sales by Country (2018-2029)
3.4.3 North America Transcatheter Aortic Valve Implantation (TAVI) System Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Facts & Figures by Country
3.5.1 Europe Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Transcatheter Aortic Valve Implantation (TAVI) System Sales by Country (2018-2029)
3.5.3 Europe Transcatheter Aortic Valve Implantation (TAVI) System Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Facts & Figures by Country
3.6.1 Asia Pacific Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Transcatheter Aortic Valve Implantation (TAVI) System Sales by Country (2018-2029)
3.6.3 Asia Pacific Transcatheter Aortic Valve Implantation (TAVI) System Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Facts & Figures by Country
3.7.1 Latin America Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Transcatheter Aortic Valve Implantation (TAVI) System Sales by Country (2018-2029)
3.7.3 Latin America Transcatheter Aortic Valve Implantation (TAVI) System Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Facts & Figures by Country
3.8.1 Middle East and Africa Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Transcatheter Aortic Valve Implantation (TAVI) System Sales by Country (2018-2029)
3.8.3 Middle East and Africa Transcatheter Aortic Valve Implantation (TAVI) System Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Transcatheter Aortic Valve Implantation (TAVI) System Sales by Type (2018-2029)
4.1.1 Global Transcatheter Aortic Valve Implantation (TAVI) System Sales by Type (2018-2023)
4.1.2 Global Transcatheter Aortic Valve Implantation (TAVI) System Sales by Type (2024-2029)
4.1.3 Global Transcatheter Aortic Valve Implantation (TAVI) System Sales 麻豆原创 Share by Type (2018-2029)
4.2 Global Transcatheter Aortic Valve Implantation (TAVI) System Revenue by Type (2018-2029)
4.2.1 Global Transcatheter Aortic Valve Implantation (TAVI) System Revenue by Type (2018-2023)
4.2.2 Global Transcatheter Aortic Valve Implantation (TAVI) System Revenue by Type (2024-2029)
4.2.3 Global Transcatheter Aortic Valve Implantation (TAVI) System Revenue 麻豆原创 Share by Type (2018-2029)
4.3 Global Transcatheter Aortic Valve Implantation (TAVI) System Price by Type (2018-2029)
5 Segment by Application
5.1 Global Transcatheter Aortic Valve Implantation (TAVI) System Sales by Application (2018-2029)
5.1.1 Global Transcatheter Aortic Valve Implantation (TAVI) System Sales by Application (2018-2023)
5.1.2 Global Transcatheter Aortic Valve Implantation (TAVI) System Sales by Application (2024-2029)
5.1.3 Global Transcatheter Aortic Valve Implantation (TAVI) System Sales 麻豆原创 Share by Application (2018-2029)
5.2 Global Transcatheter Aortic Valve Implantation (TAVI) System Revenue by Application (2018-2029)
5.2.1 Global Transcatheter Aortic Valve Implantation (TAVI) System Revenue by Application (2018-2023)
5.2.2 Global Transcatheter Aortic Valve Implantation (TAVI) System Revenue by Application (2024-2029)
5.2.3 Global Transcatheter Aortic Valve Implantation (TAVI) System Revenue 麻豆原创 Share by Application (2018-2029)
5.3 Global Transcatheter Aortic Valve Implantation (TAVI) System Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Colibri
6.1.1 Colibri Corporation Information
6.1.2 Colibri Description and Business Overview
6.1.3 Colibri Transcatheter Aortic Valve Implantation (TAVI) System Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Colibri Transcatheter Aortic Valve Implantation (TAVI) System Product Portfolio
6.1.5 Colibri Recent Developments/Updates
6.2 NVT AG
6.2.1 NVT AG Corporation Information
6.2.2 NVT AG Description and Business Overview
6.2.3 NVT AG Transcatheter Aortic Valve Implantation (TAVI) System Sales, Revenue and Gross Margin (2018-2023)
6.2.4 NVT AG Transcatheter Aortic Valve Implantation (TAVI) System Product Portfolio
6.2.5 NVT AG Recent Developments/Updates
6.3 Abbott
6.3.1 Abbott Corporation Information
6.3.2 Abbott Description and Business Overview
6.3.3 Abbott Transcatheter Aortic Valve Implantation (TAVI) System Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Abbott Transcatheter Aortic Valve Implantation (TAVI) System Product Portfolio
6.3.5 Abbott Recent Developments/Updates
6.4 Strait Access Technologies
6.4.1 Strait Access Technologies Corporation Information
6.4.2 Strait Access Technologies Description and Business Overview
6.4.3 Strait Access Technologies Transcatheter Aortic Valve Implantation (TAVI) System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Strait Access Technologies Transcatheter Aortic Valve Implantation (TAVI) System Product Portfolio
6.4.5 Strait Access Technologies Recent Developments/Updates
6.5 JenaValve Technology, Inc.
6.5.1 JenaValve Technology, Inc. Corporation Information
6.5.2 JenaValve Technology, Inc. Description and Business Overview
6.5.3 JenaValve Technology, Inc. Transcatheter Aortic Valve Implantation (TAVI) System Sales, Revenue and Gross Margin (2018-2023)
6.5.4 JenaValve Technology, Inc. Transcatheter Aortic Valve Implantation (TAVI) System Product Portfolio
6.5.5 JenaValve Technology, Inc. Recent Developments/Updates
6.6 Boston Scientific
6.6.1 Boston Scientific Corporation Information
6.6.2 Boston Scientific Description and Business Overview
6.6.3 Boston Scientific Transcatheter Aortic Valve Implantation (TAVI) System Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Boston Scientific Transcatheter Aortic Valve Implantation (TAVI) System Product Portfolio
6.6.5 Boston Scientific Recent Developments/Updates
6.7 Medtronic
6.6.1 Medtronic Corporation Information
6.6.2 Medtronic Description and Business Overview
6.6.3 Medtronic Transcatheter Aortic Valve Implantation (TAVI) System Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Medtronic Transcatheter Aortic Valve Implantation (TAVI) System Product Portfolio
6.7.5 Medtronic Recent Developments/Updates
6.8 MicroPort
6.8.1 MicroPort Corporation Information
6.8.2 MicroPort Description and Business Overview
6.8.3 MicroPort Transcatheter Aortic Valve Implantation (TAVI) System Sales, Revenue and Gross Margin (2018-2023)
6.8.4 MicroPort Transcatheter Aortic Valve Implantation (TAVI) System Product Portfolio
6.8.5 MicroPort Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Transcatheter Aortic Valve Implantation (TAVI) System Industry Chain Analysis
7.2 Transcatheter Aortic Valve Implantation (TAVI) System Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Transcatheter Aortic Valve Implantation (TAVI) System Production Mode & Process
7.4 Transcatheter Aortic Valve Implantation (TAVI) System Sales and 麻豆原创ing
7.4.1 Transcatheter Aortic Valve Implantation (TAVI) System Sales Channels
7.4.2 Transcatheter Aortic Valve Implantation (TAVI) System Distributors
7.5 Transcatheter Aortic Valve Implantation (TAVI) System Customers
8 Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Dynamics
8.1 Transcatheter Aortic Valve Implantation (TAVI) System Industry Trends
8.2 Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Drivers
8.3 Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Challenges
8.4 Transcatheter Aortic Valve Implantation (TAVI) System 麻豆原创 Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 麻豆原创 Size Estimation
10.1.3 麻豆原创 Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Companies Mentioned:

Colibri
NVT AG
Abbott
Strait Access Technologies
JenaValve Technology, Inc.
Boston Scientific
Medtronic
MicroPort

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.